Skip to Content

erlotinib

 

Definition: An oral epidermal-growth-factor (EGFR) inhibitor used in malignancies with either mutated or overactive EGFR; most commonly used in the treatment of lung cancers.

Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.
© Copyright 2017 Wolters Kluwer. All Rights Reserved. Review Date: Sep 19, 2016.
Hide